World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
Tag Archives: bioreference
BioReference Laboratories is the largest full service specialty laboratory in the United States that gives healthcare providers and patients the information to make confident healthcare decisions.
09
May
May
National Women’s Health Week is an annual initiative driven by the U.S. Department of Health and Human Services that aims to raise awareness and encourage women to make their health a priority. While finding the time and resources to properly manage one’s health may feel overwhelming, there are many actionable ways women can take to […]
05
May
May
Overall, more than 60 million Americans suffer from asthma and allergies according to the Asthma and Allergy Foundation of America (AAFA) and allergic asthma is the most common type. Each allergy season is all too familiar for those with allergies. With each bloom and breeze, all the common signs and symptoms emerge that can include […]
24
Apr
Apr
Each year, the last week of April brings a special time to recognize the dedicated individuals at the core of BioReference – our Laboratory Professionals. Since 1975, Medical Laboratory Professionals Week has been observed by the American Society of Laboratory Science (ASCLS) and 17 other national organizations, as an annual celebration recognizing the contributions of […]
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
09
Feb
Feb
Cervical cancer is one of the most preventable forms of cancer. However, each year in the United States, an estimated 13,000 new cases of cervical cancer are diagnosed and 4,000 women die of this cancer, according to the Centers for Disease Control and Prevention. Screening tests and the HPV vaccine are the keys to prevention. When cervical cancer […]
16
Nov
Nov
It’s not just flu season. It’s the flu, COVID-19, and RSV (respiratory syncytial virus) season. While the flu has been diminished for the past two years due to the COVID-19 pandemic safety measures, such as people staying home and wide-spread masking, experts suggest that this could lead to reduced population immunity.1 These factors can bring […]
OPKO Press Release MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO. He will remain as […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
PM360 Hillary M. Titus, Director of External Communications, BioReference Laboratories, Inc. As the world’s leading diagnostics labs raced to develop effective COVID-19 testing programs, BioReference Laboratories’ existing proprietary technology was already far ahead of the competition. However, the small lab was virtually unknown. In order to launch new testing services, BioReference had to become part […]
